www.fdanews.com/articles/126468-novartis-gains-new-indication-for-diovan-in-the-eu

Novartis Gains New Indication for Diovan in the EU

April 23, 2010

The European Commission has granted Diovan (valsartan) a new pediatric indication for the treatment of hypertension in children and adolescents 6–18 years of age.
TradingMarkets